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Simon BA, Kaczka DW, Bankier AA, Parraga G. What can computed tomography
and magnetic resonance imaging tell us about ventilation?. J Appl Physiol 113: 647–657,
2012. First published May 31, 2012; doi:10.1152/japplphysiol.00353.2012.—This
review provides a summary of pulmonary functional imaging approaches for deter-
mining pulmonary ventilation, with a specific focus on multi-detector x-ray computed
tomography and magnetic resonance imaging (MRI). We provide the important
functional definitions of pulmonary ventilation typically used in medicine and physi-
ology and discuss the fact that some of the imaging literature describes gas distribution
abnormalities in pulmonary disease that may or may not be related to the physiological
definition or clinical interpretation of ventilation. We also review the current
state-of-the-field in terms of the key physiological questions yet unanswered
related to ventilation and gas distribution in lung disease. Current and emerging
imaging research methods are described, including their strengths and the
challenges that remain to translate these methods to more wide-spread research
and clinical use. We also examine how computed tomography and MRI might
be used in the future to gain more insight into gas distribution and ventilation
abnormalities in pulmonary disease.
pulmonary physiology; lung imaging; ventilation; gas distribution; ventilation
defects
OVERVIEW AND INTRODUCTION
Numerous questions in physiology and medicine have de-
rived solutions or answers from an improved understanding of
regional anatomic and functional abnormalities that were qual-
itatively described or quantitatively measured using medical
imaging. For example, over the past four decades, improve-
ments in cardiovascular imaging (9, 63) have paved the way
for new regional imaging techniques that have resulted in
targeted treatments (17) and vastly improved patient outcomes
(30). Clinical applications of anatomic, morphologic, and func-
tional pulmonary imaging have also resulted in improved
diagnosis and monitoring in thoracic oncology, as well as in
non-neoplastic focal and diffuse lung diseases. There have also
been substantial advancements in regional imaging of pulmo-
nary mechanics, as well as ventilation and perfusion in ob-
structive lung disease, although many of these research tools
have not yet been translated to routine clinical use. In particular
for clinical applications, static anatomic imaging has domi-
nated, although current research in functional imaging demon-
strates great potential for these tools to enhance our under-
standing of structure-functional relationships in the lung. In
this regard, we view quantitative pulmonary functional imag-
ing methods as innovative technologies that provide new ways
to answer open clinical questions. Advances in imaging over
the last decade provide the physiologist with new tools to
investigate lung disease as a regionally heterogeneous system.
Driving the development of regional and quantitative lung
imaging techniques are many unanswered questions in pulmo-
nary physiology, along with the growing economic and societal
burdens of lung disease with limited therapeutic options. Si-
multaneously, the trend toward individualized diagnosis and
treatment requires sophisticated tools to phenotype diseases
and to monitor the effectiveness of treatment. In this regard,
pulmonary structure-function imaging tools may provide met-
rics and answers to unsolved pulmonary problems. In this
paper, we discuss the potential for computed tomography (CT)
and magnetic resonance imaging (MRI) to provide quantitative
insight into pulmonary ventilation. Our main focus is ventila-
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tion, as it is the primary function of the respiratory system. We
also provide critical definitions and examples in an effort to
reconcile the occasional divergent viewpoints of the physiolo-
gist and imaging scientist. We then summarize recent imaging
research in that context. Underscoring and driving the devel-
opment of all pulmonary imaging approaches is the under-
standing that global measurements such as those provided by
spirometry are insensitive to early disease and that the regional
sensitivity of imaging measurements can be exploited to iden-
tify ventilation or gas distribution abnormalities that cannot be
detected by spirometry.
As several excellent reviews of single photon and positron
emission tomography (SPECT and PET) are now available (12,
24, 34, 60), we will mainly focus on functional x-ray CT and
MRI and contrast these techniques with other imaging ap-
proaches.
DEFINITIONS
An essential function of the respiratory system is the deliv-
ery of fresh gas, including oxygen, from the environment to the
alveoli and the removal of CO2 from the body to the external
environment. Pulmonary physiology provides clear definitions
for this function and derives the term total pulmonary ventila-
tion or minute volume (V˙ E) as the volume of gas entering the
lung per unit time:
V˙ E VTf (1)
where total ventilation V˙ E (in units of ml/min) is simply the
tidal volume (VT) delivered times the breathing frequency per
minute (f). Some of the entering tidal volume fills the conduct-
ing airways, and thus never reaches the alveoli or participates
in gas exchange. Subtracting this ventilation of the anatomic
dead space (Vd) defines alveolar ventilation (V˙ A):
V˙ A VT Vd f (2)
It is assumed that V˙ A is defined by the delivery of fresh gas
(i.e., gas that does not contain CO2) to the alveoli. Similarly at
end expiration, the gas residing in the dead space has the same
composition as alveolar gas, and the subsequent reentry of
dead space gas to the alveoli does not constitute fresh gas
delivery and thus cannot contribute to CO2 removal. V˙ A can
alternately be defined in terms of the ratio of steady state CO2
production and the alveolar PACO2, emphasizing the primacy of
CO2 removal in alveolar ventilation:
V˙ A K
V˙ CO2
PACO2
 K
V˙ CO2
PaCO2
(3)
where K is a constant converting the partial pressure of CO2 to
volume (68). Note that under ordinary circumstances, the more
easily measured arterial PaCO2 is very close to the alveolar
PACO2 and can be used to estimate alveolar ventilation in
normal lungs. Thus to a physiologist, alveolar ventilation is a
steady-state process by which CO2 is removed from the lung.
Gas transport, even of fresh gas, to an alveolar region that is
not perfused (and thus does not contain CO2) does not there-
fore contribute to alveolar ventilation or gas exchange but
rather to dead space ventilation. Particularly in the diseased
lung, the delineation of the dead space from gas exchanging
regions is not distinct, and the term physiological dead space is
used to designate the volume of the lung that functionally does
not contribute to CO2 removal.
Although these relationships are usually described for the
entire lung, they also hold true at the regional level, with local
alveolar PACO2 related to the balance of local CO2 delivery to
those alveoli via regional perfusion and the local rate of CO2
removal via regional ventilation. Note that this is a particularly
restrictive definition of alveolar ventilation with respect to
effecting respiratory gas exchange; in a broader, more mechan-
ical sense alveolar ventilation could be defined as the delivery
of fresh gas to the alveolar zone, independent of CO2 presence.
Most imaging techniques for measuring regional ventilation in
fact depend on quantifying the rate of accumulation and/or
elimination of a nonabsorbed, inhaled tracer gas in the lung
periphery. This approach differs from traditional compartmen-
tal modeling of alveolar ventilation and CO2 removal and thus
cannot distinguish alveolar from dead space ventilation. If the
tracer gas is either taken up by the pulmonary circulation or
delivered to the alveoli from the circulation, similar to the
path of the respiratory gases, then it is possible to separate
dead space from alveolar ventilation as well as estimate
ventilation:perfusion (V˙ /Q˙ ) ratios, either on a whole lung
basis, as with the multiple inert gas elimination technique
(62), or regionally, with imaging approaches (34, 43). Thus
we urge investigators imaging ventilation to consider
whether the distinction between gas transport within the
lung and gas exchange with the circulation is important in
interpreting their results.
Specific ventilation (sV˙ r) is defined as the regional alveolar
ventilation normalized by the regional gas volume (Vr), usually
at end expiration:
sV˙ r V˙ A,r ⁄ Vr (4)
This parameter arises directly from indicator-dilution tech-
niques that assume an exponential rise of a tracer gas (41).
Because ventilation is normalized to a region’s gas volume,
specific ventilation is a convenient parameter to compare
ventilation in different arbitrarily defined pulmonary regions of
interest (ROI), because absolute ventilation will increase with
the region size.
A similar parameter introduced in the MR literature is the
fractional ventilation per breath r, defined as r  Vf/(VfVo),
where Vf is the volume of fresh gas entering a region during a
breath and Vo the volume of old gas still present in the region
at the end of the breath, including the dead space gas (21).
Whereas sV˙ r describes the fresh gas entering a lung region (per
unit time) normalized to the region’s volume at the time of
imaging (end-expiratory, mean lung volume, or end-inspira-
tory), the fractional ventilation r describes the fresh gas (per
breath) entering a region normalized to end-inspiratory vol-
ume. Thus, if sV˙ r is normalized to regional end-inspiratory
volume, r and sV˙ r are equivalent; if sV˙ r is normalized to
end-expiratory volume then they are related by 1/r 11/ sV˙ r.
End-inspiratory imaging of a tracer gas tends to overestimate
the regional ventilation because the conducting airways are
filled with the inspired tracer concentration, which increases
the apparent rate of rise of the tracer in the alveolar gas by
partial volume averaging. For the same reason, end-inspiratory
imaging may introduce regional artifacts because of the vary-
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ing presence of conducting airways between the inner and
outer lung.
Factors affecting the regional distribution of ventilation
include local parenchymal compliance, airways resistance and
obstruction, regional intrapleural pressure, interdependence ef-
fects, tidal volume, gas properties, and respiratory frequency
and inspiratory flow rate. Important for the interpretation of
pulmonary images, the regional distribution of steady-state,
alveolar ventilation is related to (but not identical to) the
distribution of an inhaled contrast agent or tracer gas during
a deep inspiration, nor is it equivalent to the distribution of
directly measured changes in regional lung volume. First,
the distribution of inspired gas may differ from steady-state
breathing for a breath that has different mechanical parameters
(flow rate, volume) or gas properties (density, viscosity); sec-
ond, gas flowing to a lung region without blood flow, for
example attributable to a pulmonary embolus, contributes to
dead space but not alveolar ventilation. As discussed below,
these factors must be considered in formulating questions to
address with ventilation imaging as well as for interpreting
functional images.
POSTURE AND BREATHING MANUEVERS
Another important consideration for physiologists and im-
aging scientists is that lung volumes, ventilation, and other
mechanical measurements are often made with the subject
seated upright, with the most gravitationally dependent regions
against the diaphragm. In the upright posture, ventilation in
these inferior regions is typically increased relative to superior
regions, reflecting variations in regional lung and chest wall
mechanics. Physiological insights regarding global ventilation
heterogeneity (i.e., the variance of ventilation distribution)
have been obtained using indirect measurements in upright
subjects, such as single- or multiple-breath nitrogen washouts
(62, 66) and computational modeling (15). By contrast, most
imaging is performed with patients in the supine or prone
position, and thus measures regional ventilation distribution
under very different conditions compared with upright mea-
surements. Such differences are important to keep in mind as
we review key findings relating imaging to ventilation. Al-
though it is true that many physiological tests may be per-
formed supine to better compare results with imaging (i.e.,
spirometry), most of human physiology (except for sleeping) is
undertaken while upright, arguing for the development of
regional imaging methods that can be performed on subjects in
the upright position.
Another important consideration is the inhalation and
breath-hold maneuvers undertaken when acquiring CT and
MRI and how these compare to standard pulmonary function
tests. In Table 1, we summarize some of these inhalation and
breath-hold approaches (already established in the literature)
for the static and dynamic MR and CT imaging techniques
discussed in this review.
UNANSWERED QUESTIONS FROM THE PHYSIOLOGIST
Because ventilation is the primary function of the lung, it
stands to reason that pulmonary disease is associated with
abnormalities in ventilation. However, the lung has considerable
reserve capacity, and as such may harbor significant abnormalities
not easily detected from clinical symptoms or indices of global
lung function. For example in chronic obstructive lung disease
(COPD), abnormalities of distal or small airways may not be
apparent because of their relatively small contribution to flow
measured at the mouth, resulting in minimal alterations in
FEV1 or FVC. Nevertheless, global physiological measure-
ments made at the airway opening have been used to infer
ventilation and its heterogeneity throughout the lung. These
well-established methods, based on flow, volume, and detec-
tion of inert gas wash-in and wash-out profiles, were devel-
oped to address mechanistic questions regarding normal and
abnormal lung function (18, 25, 67). The critical need for
spatial or regional estimates of lung function has motivated
the application of imaging methods to these physiological
questions.
For patients with chronic diseases such as asthma or COPD,
abnormalities of the airways and parenchyma may go unde-
tected by spirometry and the patient themselves because the
lung is relatively overengineered for day-to-day living. This
chronicity of unresolved inflammation results in progressive
worsening of pathology (16). In asthma, some symptoms can
be managed with -agonists, corticosteroids, or leukotriene
inhibitors. However, in COPD, deterioration in lung function is
usually irreversible, and the thoracic cavity becomes larger as
an adaptive response to air trapping, increased compliance, and
decreased expiratory flows (20, 23). All of these important
physiological changes may be detectable on a regional basis
prior to apparent clinical symptomatology and thus less ame-
nable to treatment. Importantly, many therapies for asthma and
COPD follow the inhaled route, and the spatial heterogeneity
of disease may also result in heterogeneous therapy delivery.
Hence regional imaging methods and measurements may be
used to help guide therapy (for regional therapy such as
Table 1. Summary of inhalation and breath-hold approaches
Breath Hold Free Breathing/Gated
CT
Inspiration/expiration  No
Xe CT  Gated to controlled or trained breathing
Dual energy Xe CT Fixed volume inhalation for single breath method Gated to controlled or trained breathing
Dynamic (4DCT) No Tidal breathing
MRI
Hyperpolarized Xe/He Fixed volume dose from FRC or RV Inhalation and exhalation dynamic possible
O2-enhanced 1H No Tidal breathing
1H-UTE Fixed volume inhalation from FRC or RV No
4D (FD) 1H No Tidal breathing
CT, computed tomography; UTE, ultrashort echo time; FD, Fourier decomposition.
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thermoablation or lung reduction strategies) or spatially resolve
the effects of therapy. As another example, in syndromes such
as acute lung injury, regional abnormalities of ventilation are
very common, and mechanical ventilation can accelerate dis-
ease progression. Current approaches to ventilator manage-
ment attempt to restore collapsed or flooded lung regions of
ventilation lung while simultaneously avoiding overdistension
of already open lung regions, in effect reducing mechanical
stresses and ventilation heterogeneity (37, 59). Clearly, there is
a need for better regional assessment of lung function in
patients with acute and chronic lung disease.
Accordingly, some of the important mechanistic questions
for the physiologist interrogating these pathways relate to
1) regional detection and measurement of structure-function
abnormalities prior to symptomatology; 2) understanding re-
gional pathophysiology and measuring subtle regional re-
sponses to therapy; 3) improved phenotyping or patient strat-
ification based on structural and functional abnormalities; and
4) utilizing regional characterizations to predict important
clinical outcomes such as acute exacerbations, disease progres-
sion, and mortality.
SOLUTIONS AND ANSWERS PROVIDED BY IMAGING
The development of functional imaging protocols in pul-
monary physiology is resource intensive, and immediate
benefits to patients with lung disease are not yet apparent.
Thus the question remains: what is the clinical utility of
functional lung imaging? The answer is straightforward: in
vivo medical imaging, even at relatively low spatial and
temporal resolutions, provides a foundation for understand-
ing pulmonary pathophysiology as heterogeneous, regional
phenomena (38). Gas phase tracers or contrast agents can be
used to estimate gas distribution and even regional ventila-
tion using single breath or multibreath methods. Methods
that measure regional oxygen or carbon dioxide concentra-
tion or use tracers that exchange with the circulation can be
used to estimate important local ventilation/perfusion rela-
tionships. Image registration techniques quantify spatial
parenchymal deformation and strain, providing a surrogate
for ventilation (36) and quantifying local pulmonary me-
chanical properties. We summarize x-ray CT (with or with-
out the use of inhaled xenon or krypton signal enhancement
and using single-energy or dual-energy approaches) and
MRI in terms of their corresponding strengths, weaknesses,
and availability for research and patient care. In Table 2, we
provide a summary of these imaging methods, their spatial
and temporal resolution, and typical measurements that can
be generated or derived from the images acquired. We think
it is also important to acknowledge that there has been
limited experience in comparing physiological tests and
images in the same person, even with the availability of
three-dimensional (3D) volumetric lung measurements de-
rived from CT and MRI. For some examples in Table 2, we
provide some of the basic relationships that have been
determined between imaging and more established pulmo-
nary function measurements.
Table 2. Summary of imaging methods
Time for Exam Radiation Dose* Spatial Resolution Temporal Resolution Imaging Measurements
CT
Inspiration/expiration 5–10 min Total 2–5 mSv for 2-
whole lung
scans
Up to 0.5 mm
isotropic
Up to 0.3 s slice,
5 s whole lung
Specific volume change
Xe CT approximately 10–20
min Total
High for washin/
washout
studies-
depends on
protocol and
extent of lung
imaged
Up to 0.5 mm
isotropic
Up to 0.3 s slice,
5 s whole lung
Specific ventilation
Dual energy Xe CT 5–10 min Total High for washin/
washout
studies 1–5
mSv for single
breath
Up to 0.5 mm
isotropic
Up to 0.3 s slice,
5 s whole lung
Specific ventilation, inhaled
gas distribution
4DCT 10–20 min Total 30–40 mSv for
low pitch
helical study
Up to 0.5 mm
isotropic
Up to 0.3 s slice,
5 s whole lung
Specific volume change
MRI
Hyperpolarized Xe/He approximately 5–10
min Total
None 2D 3mmx10 mm
3D isotropic
3 mm voxels
15 s acquisition 3D
40 cmx 40 cmx
30 cm every
20–30 s
Inhaled Gas distribution
VDV, VDP, PVV
O2-enhanced 1H approximately 30–60
min Total
None 3 mm isotropic
voxels
Specific ventilation
UTE 1H static approximately 5–10
min Total
None 1 mm voxels 3D 40 cmx 40 cmx
30 cm every
20–30 s
1H Signal intensity
4D (FD) 1H approximately 20–30
min Total
none 3 mm voxels 90 s acquisition
*mSv, milliSievert WBDE (whole body dose equivalent). Compare with 3–10 mSv for standard dose chest helical CT, 1–2.5 mSv for low-dose helical chest
CT, average background radiation exposure of 3–4 mSv/yr.
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Multidetector X-Ray Computed Tomography
Since its introduction in the 1970s, CT has provided tremen-
dous insight into the structural and anatomic basis of lung
disease that has been supplemented in recent years by its
increasing ability to provide functional imaging measurements,
including estimates of regional pulmonary ventilation, perfu-
sion, and mechanics. Among the numerous advantages that CT
provides include its wide availability and high spatial resolu-
tion, with concomitant anatomic and pathologic correlation.
Currently available CT scanners are capable of true dynamic
volumetric imaging with subsecond temporal resolution, al-
lowing imaging of the entire thorax in less than 3 s, i.e., within
a single breathhold even in dyspneic patients. Two major
challenges still remain, however, and these are related to
lowering the exposure to ionizing radiation by incorporating
imaging protocol optimization, and other methods, and trans-
lating practical image processing tools into mainstream re-
search and clinical workflows. For example, conventional, 4D
and dual energy thoracic CT still results in 100–500 times
the dose of a chest x-ray radiograph (or 1–5 times the annual
background radiation).
Tissue contrast in CT stems from the differential attenuation
of x-rays by different atomic materials measured in Hounsfield
units (HU), which is scaled in an arbitrary and linear fashion
with zero defined as the attenuation of x-rays in water and, at
the other end of the scale, 1,000 for the attenuation of x-rays
in air. The volume averaged signal from the lung parenchyma
is linearly related to the proportion of air and tissue; as lung
volume increases, the quantity of gas increases while the tissue
remains the same and, therefore, overall lung density decreases
as the lung expands. Changes in CT density provide accurate
measurements of regional and global lung air and tissue vol-
umes as well as an indication of the heterogeneity of lung
expansion. To allow quantitation of regional gas movement
and mixing, stable radio-dense gaseous xenon (Xe) or krypton
(Kr) can be used as tracers or contrast agents (32, 48). Because
Xe gas is denser than air, the CT density of an airspace
containing Xe increases linearly with Xe concentration (80
HU maximum density increase with 40% Xe at 80 kV). The
rate of Xe wash-in and -out of the parenchyma during steady-
state breathing can therefore be estimated from serial CT
images on a high-resolution, regional basis and used to quan-
tify regional specific ventilation. This method entails repeat
imaging with substantial radiation exposure and the anesthetic
properties of Xe limit its concentration in humans (33). There-
fore, approaches to reduce the number of images, including
single breath methods, and to increase sensitivity and signal-
to-noise ratio (SNR), such as dual energy Xe-CT have also
been explored. Dual energy Xe-CT uses the differential absor-
bance of xenon at energies above and below its Kedge to
generate an image of the contrast agent alone, reducing the
noise associated with the density of the lung parenchyma (11).
As discussed earlier, the use of an airway tracer gas to measure
ventilation may not necessarily correlate directly with either
regional CO2 elimination or O2 uptake, because both are
determined by regional V˙ /Q˙ ratio rather than V˙ A alone and it
assumes that the rate of transfer of the tracer into and out of the
alveoli is similar to that of CO2 elimination. Certainly, this
approach is subject to the limitation of the potential differences
in gas transport and changes to ventilation distribution of the
extremely dense Xe gas, with 40% Xe in air50% denser than
air alone (14). In this regard, Kr gas is theoretically more
suitable because it is 1/3 less dense than Xe and has no
anesthetic side effects; however, because it is also less ra-
diodense the contrast enhancement achieved is only 25–30% of
that of Xe (13).
Xe is moderately soluble in blood, and its uptake by the
circulation is the basis for its use in the measurement of
cerebral blood flow (26) and as an inhaled anesthetic (47). This
uptake has been used to successfully estimate regional V˙ /Q˙
ratios from Xe-CT images (43), although translating this tech-
nique to clinical use will be challenging because maximizing
the signal-to-noise ratio required the use of high Xe concen-
trations that would be anesthetic in humans. Alternatively,
methods for measuring regional pulmonary perfusion with CT
from repeat imaging during bolus contrast injection (19) or
coregistered SPECT (10) can potentially be used to estimate
regional V˙ /Q˙ ratios.
An alternate approach to estimating regional ventilation with
CT is to image the lung at two volumes (ideally end expiration
and end inspiration) and then exploit the high-resolution ana-
tomic detail of CT images to measure regional changes in lung
volume [specific volume change, sVol  (volume change)/
(initial volume)]. sVol is an estimate of regional ventilation
only if one assumes that the volume change occurred because
of the inflow of fresh gas in to the region. Nonrigid lung
registration techniques can be used to map anatomic details,
voxel by voxel, from one lung volume to the other (31, 61) and
the volume change measured from the calculated deformation
of each voxel (3) or, alternatively, from the density change of
the corresponding mapped lung regions (29, 31). Compared
with the Xe-CT approach, this so-called 4DCT ventilation
estimate cannot distinguish actual inflow of fresh gas (ventila-
tion) from redistribution of alveolar or dead space gas (pen-
delluft), but it does provide a reasonable surrogate for regional
ventilation that has been validated in healthy lungs (29, 61).
Evolving techniques for gated imaging or retrospective re-
construction of the whole lung during uncontrolled or “free”
tidal breathing make this technique increasingly attractive
for use in patients (8, 31). As shown in Fig. 1, this approach
also provides novel insights into regional lung mechanical
behavior on a finer spatial scale than previously possible
(36). A direct comparison between 4DCT and 3He-MRI
estimates of pulmonary ventilation is provided in Fig. 2. It
is important to note, however, that with all methods that
involve multiple image acquisitions and the requirement for
image registration, there is a potential source of error
because of the elastic nature of the lung. More technically
demanding, nonrigid registration methods are required in
these cases, although there is still the potential for error in
the generation of ventilation maps. We also must acknowl-
edge that in such cases where static or dynamic imaging is
suggestive of ventilation abnormalities, in most cases there
has been no comparison to ground truth (histopathology) so
the exact etiology of such abnormalities is not known.
Therefore, for example in Fig. 2, there is no way to nor-
malize color scales for 4DCT and 3He-MRI because ground
truth is not known. By way of example, we note that the
differences in relative intensities of gas in the trachea
(4DCT trachea is devoid of gas compared with 3He-MRI
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that is gas filled) might reflect the differences in the breath-
ing maneuvers used for image acquisition (see Table 1).
Magnetic Resonance Imaging
In contrast to CT-based methods, the use of MRI for assess-
ment of pulmonary function is relatively recent. Except in very
limited situations, pulmonary MRI is still considered a research
tool. The reasons for this relate directly to the structure and
function of the respiratory system and the physics of MRI, both
of which represent fundamental challenges that have limited
the utility of conventional 1H-MRI for pulmonary disease.
Conventional MRI tissue contrast stems from the perturbation
of water- and fat-bound hydrogen atoms [otherwise known as
protons (1H)] using a burst of radiofrequency energy. The MRI
signal derives from the tiny net fraction of protons that are
aligned with the magnetic field of the scanner, and after
application of radiofrequency radiation, these undergo realign-
ment that is detected and converted into the image. The lung
has very low tissue and proton density, and therefore pulmo-
nary MRI, even when optimized for the lung, results in images
(39, 42) with lung regions mainly devoid of contrast, tissue,
and morphological information (Fig. 3). Compounding this, the
different magnetic environments related to the tightly spaced
air and tissue compartments result in so-called magnetic sus-
ceptibility artifacts that accelerate signal decay, i.e., less signal
is available for imaging in a given time window compared with
organs with a higher proton density such as, for example, the
liver or the muscles. For these reasons, the development of
conventional pulmonary MRI has been mainly overlooked as a
clinical application, although its diagnostic potential was rec-
ognized nearly three decades ago (54). Pulmonary applications
Fig. 2. Hyperpolarized 3He-MRI coregistered with 1H-MRI as well as 4DCT
acquired within 7 days in a single non-small cell lung cancer patient. Top: axial
reconstructions; bottom: coronal slices. Magnetic resonance imaging (MRI)
was obtained in the coronal plane during inspiration breath hold, after inhala-
tion of a 1 liter gas mixture of hyperpolarized 3He and ultra-high purity N2 gas
from functional residual capacity. 1H-MRI preceded 3He-MRI by 5 min and
the 1H- and 3He-MRI slices were rigidly coregistered using the carina for
fiducial landmarks. To generate the 4DCT ventilation maps, first, thoracic CT
images were acquired during a single tidal breathing maneuver (120 kV,
60–120 mA, rotation time of 0.5 s, 360° reconstruction, pitch 0.1). CT
images were reconstructed at 10 different respiratory phases and tagged as a
percent of full inspiration, with in plane resolution of 1.0 mm. Deformable
image registration methods were used to generate a ventilation map. Coregis-
tered 1H (gray scale)- and 3He-MRI gas distribution images show gas in red,
and focal ventilation defects are clearly shown where the 1H thoracic cavity is
exposed (in black) in the absence of gas. 4DCT ventilation maps are color-
coded differently such that red, orange, and yellow correspond to regions of
greater ventilation; and blue, purple, and black correspond to regions of lower
or no ventilation with green representing average values. Note that there is a
qualitative regional correspondence between 4DCT regions of decreased
ventilation and MRI regions of ventilation defects.
Fig. 1. Regional parenchymal deformation maps obtained using CT image
registration in transverse (A) and coronal (B) sections for a supine dog at
baseline and following acute lung injury (ALI) induced by the infusion of oleic
acid into the pulmonary artery. Computed tomography (CT) images were
obtained during constant breath holds at 5, 10, 15, and 20 cmH2O transrespi-
ratory pressure. Registrations were performed for 3 different inflation pressures
pairs: 5–10 cmH2O, 10–15 cmH2O, and 15–20 cmH2O. Volume changes are
color coded such that yellow, orange, and red correspond to expansion; blue
and purple to contraction; and green to no change in volume. Note that during
baseline conditions, the lungs exhibited fairly uniform expansion throughout
the transverse section for lower inflation pressures, although the registration
algorithm does predict small regions of compression occurring near the
mediastinum. For more moderate inflation pressures, expansion occurs pref-
erentially in more dependent regions. Following ALI, expansion fields are
more heterogeneous at all inflation pressures, with regions of relative com-
pression interspersed throughout the transverse sections. [Figure modified from
Kaczka et al. (36) with permission.]
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of 1H-MRI have been further developed (4, 5) with renewed
interest in the potential of pulmonary MRI stimulated by novel
pulmonary functional MRI techniques using noble gas contrast
agents (28) as well as oxygen-enhanced (53) and Fourier-
decomposition 1H-MRI (6, 7).
Noble gas MRI, first described for 129Xe (1), provides a way
to visualize in relatively high spatial resolution the distribution
of inhaled gas. In particular, so-called static ventilation imag-
ing provides a map of gas distribution, with imaging typically
taking place with the subject in breath hold after inhalation of
a discrete volume of magnetized (or hyperpolarized) helium or
xenon gas. As shown in Fig. 3, the inhaled gas provides a way
to estimate gas distribution after a single inhalation in a variety
of subjects. In healthy young adults, a single inhalation and
breath hold of hyperpolarized 3He gas results in homogeneous
signal, suggesting that all areas of the lung are participating
equally in gas distribution (Fig. 3A). In contrast, characteristic
volumetric focal defects are observed in COPD and asthma and
even in otherwise healthy elderly never-smokers (57, 58) as
regions that do not appear to contain gas signal (Fig. 3, B-D).
These are thought to correspond to areas of the lung that do not
participate in ventilation or perhaps are poorly ventilated dur-
ing steady state. Following a single inhalation from FRC and
breath hold of tracer gas, focal 3He or 129Xe gas distribution
abnormalities (Fig. 4) can be directly quantified. Historically,
such abnormalities were qualitatively evaluated as mild, mod-
erate, or severe (2, 65) and then as the field progressed,
ventilation defects were counted or scored based on a cluster of
voxels appearing to reflect gas intensities at or below the
background noise. Manual segmentation of gas distribution
abnormalities was also undertaken to generate the absolute
volume of the focal defects as the ventilation defect volume
(VDV) (58), the normalized ventilation defect percent (VDP)
(50, 51), and the percent ventilation volume (PVV) (70), all of
which have excellent reproducibility (50). It is important to
note, however, that all these functional measurements of the
parenchyma depend on gas flow or diffusion through the
airways, providing an indirect measurement of airway patency
and function (44). Unfortunately, the exact etiology of such gas
distribution abnormalities is not known, making it difficult if
not impossible to understand if such defects are attributable to
airway closure and/or narrowing or perhaps bullous disease (in
COPD). Because such defects do not appear to be random but
appear regionally fixed and temporally persistent in individual
subjects with COPD and asthma, this suggests structural ab-
normalities such as airway narrowing or closure that is not
intermittent. Another consideration is that defects likely reflect
time constants for filling that are longer than the relatively
short breath-hold static snapshot that is typically acquired. In
other words, such images are acquired as a static breath-hold
snapshot within the time course of a typical 10- to 15-s scan
(52), so the relationship between these functional abnormalities
to structural abnormalities and to ventilation (at equilibrium) is
not completely clear. What is clear, however, are the numerous
advantages of single breath-hold imaging in terms of time,
expense, simplicity, patient comfort, and compliance and all of
Fig. 3. Hyperpolarized 3He-MRI of gas distribution
(in red) coregistered to 1H-MRI of thoracic cavity
(gray scale) of a healthy young never-smoker (A),
older never-smoker (B), asthma (C), and COPD (D).
MRI was obtained in the coronal plane during in-
spiration breath hold, after inhalation of a 1 liter gas
mixture of hyperpolarized 3He and ultra-high purity
N2 gas from functional residual capacity. 1H-MRI
preceded 3He-MRI by 5 min and the 1H- and
3He-MRI slices were coregistered using rigid regis-
tration methods using the carina for fiducial land-
marks. Coregistered 1H (gray scale)- and 3He-MRI
gas distribution images show gas in red, and focal
ventilation defects are clearly shown where the 1H
thoracic cavity is exposed (in black) in the absence
of gas. Note the absence of gas distribution abnor-
malities in A for the healthy young never-smokers,
but there are qualitative differences for the elderly
never-smoker and much more obvious abnormalities
in asthma (C) and COPD (D). Some qualitative
differences can also be observed in the gas distribu-
tion obvious in the trachea, although for all subjects,
the breath-hold maneuver was the same.
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these issues have implications for clinical translation. To ad-
dress this issue, in Fig. 2 we show a recent direct comparison
of a static breath hold 3He-MRI with dynamic 4DCT imag-
ing—both of which can be used to estimate surrogates of
ventilation. As shown, there is excellent spatial or regional
correlation between gas distribution abnormalities shown using
both methods, suggesting that 3He-MRI ventilation defects
may indeed be related to airway constriction that also results in
4DCT gas distribution defects that can be generated over a tidal
breathing cycle.
Beyond static ventilation imaging with hyperpolarized 3He,
an elegant dynamic approach was recently described whereby
a single breath hold of 3He gas was employed and the rela-
tionship was determined between well-established pneumato-
graph and 3He-MRI measurements of inert gas washout (22).
Pertinent to this review, the novelty of this study directly
relates to the use of imaging and pneumotach measurements to
calculate TLC and this allows for a better and regional under-
standing of inert gas washout measurements. The imaging and
physiological measurements were in good agreement, showing
the predicted regional differences in ventilation as evidenced
by differences in residual 3He gas present in the lung after
multiple breaths of fresh air. The same team took advantage of
time-delayed or time-resolved imaging to directly visualize
delayed 3He gas distribution in COPD into regions of the lung
that they suggested was due to collateral ventilation (49),
providing an important regional description of this critical
physiological mechanism.
Finally, we end this discussion of MRI measurements of
ventilation and surrogates of ventilation by returning to more
conventional 1H-MRI without the use of polarized tracer gases.
As already mentioned, lung tissue (parenchyma) MRI can be
performed with very short echo times (otherwise known as
ultrashort echo time MRI or UTE), thereby minimizing arti-
facts related to the air-tissue interfaces in the lung (27). In this
way, and with subjects in breath hold, images can be acquired
to identify regions of low proton intensity that are mainly
devoid of tissue (tissue destruction related to bullae/emphy-
sema) (56) or regions of higher proton density that may be
related to fluid infiltrates or edema (40, 45, 46, 69). In contrast
to this structural information, functional oxygen-enhanced 1H-
MRI can also be employed that relies on the innate contrast
provided by air or oxygen and the fact that it is weakly
paramagnetic, decreasing the longitudinal relaxation time (T1)
of the lung parenchyma (35, 55, 64). Accordingly, the change
in O2 concentration in lung tissues is reflected by a local
change in T1, and this strictly depends on the rate of change of
alveolar O2 concentration—itself a function of the regional
specific ventilation. Oxygen-enhanced 1H-MR images are typ-
ically acquired over a series of breathing maneuvers as a pair
of images—one set of images acquired with the subject re-
quired to inhale oxygen from a mask at concentrations higher
than air (typically 100%) and another set of images acquired
with the subject inhaling air (21% oxygen). The recent appli-
cation of this method to describe the vertical distribution of
regional ventilation in human subjects (64) provides a good
Fig. 4. Conventional 1H-, hyperpolarized 3He- and 129Xe-MRI of a single subject each with COPD and asthma. 1H-MRI of the thoracic cavity (gray scale) was
obtained in the coronal plane during inspiration breath hold, after inhalation of 1 liter of ultra-high purity N2 gas from functional residual capacity (FRC). Within
3 min, the same subject inhaled a 1 liter mixture of hyperpolarized 3He gas mixed with N2 gas from FRC for static ventilation imaging of 3He gas distribution
(shown in red) acquired in a 15 s breath hold. Approximately 3 min later, the subject inhaled a 1 liter mixture of hyperpolarized 129Xe gas mixed with 4He from
FRC for static ventilation imaging of 129Xe gas distribution (shown in purple) acquired in a 15 s breath hold. Note the qualitative differences in gas distribution
abnormalities that are obvious between 129Xe- and 3He-MRI for both subjects. It is also important to note that the exact etiology of such gas distribution
abnormalities has not yet been established. Such differences between 3He- and 129Xe-MRI gas distribution may be attributable to differences in the gas properties
such as diffusion, viscosity, or perhaps tissue solubility.
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example of fruitful collaborations between physiologists and
imaging scientists to address fundamental questions in pulmo-
nary medicine. In a different application that does not involve
oxygen enhancement, tidal breathing of room air can be esti-
mated using dynamic ultra-short echo time 1H-MRI, using the
1H signal intensity of the lung tissue in each voxel that changes
as the lung expands and contracts when air moves in and out of
the lung. Ingeniously, the Fourier decomposition (FD) of the
1H signal intensity fluctuations that occur during normal tidal
breathing of room air can be used to dissect the ventilation (air
in and out component of the sinusoidal 1H signal intensity time
curve) and the perfusion (blood in and out component of the
sinusoidal 1H signal intensity time curve) signals (7). With
appropriate registration of the inspiratory and expiratory
images, 1H ventilation and perfusion maps can be generated
(6). The strength of this approach is the use of conventional
scanning equipment and pulse sequences, thus translating
the power of functional MRI to any scanner or patient,
without the need for magnetized contrast agents or other
specialized equipment. Limitations or drawbacks of dy-
namic or FD MRI for the generation of ventilation images
relate to the need for complex image registration algorithms
and excellent reproducibility between tidal breaths to ensure
adequate image registration.
FUTURE RESEARCH DIRECTIONS AND CHALLENGES FOR
THE FUTURE
A variety of CT- and MRI-based methods may now be
used for the evaluation of regional lung function, including
ventilation. To move such imaging techniques into main-
stream scientific research and clinical medicine, tight inte-
gration of physiology and imaging science as interdisciplin-
ary fields will be required. Early detection of regional
structure-function abnormalities using functional imaging
will allow for the testing and development of therapies
based on appropriate physiological and anatomic endpoints.
Understanding regional pathophysiology and its response to
treatment requires accurate and reproducible imaging pro-
tocols that are codeveloped by physicists and physiologists
with appreciation of the subtle diagnostic information pro-
vided by such measurements. Patient phenotyping requires
both clinical and scientific awareness of lung disease and the
complementary relationship between clinical findings and
imaging data. Ultimately functional lung imaging must be
evaluated as important and reliable predictors of clinical
outcomes, such as acute exacerbations, progressive func-
tional deterioration, and mortality.
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